Quale sarebbe il prezzo per Medigene AG (MDG1)

Il prezzo per Medigene AG (MDG1) è $0.14942078

Qual è la capitalizzazione di mercato per Medigene AG (MDG1)

La capitalizzazione di mercato per Medigene AG (MDG1) è $3.86M

Medigene AG (MDG1) Frazionamenti Azionari

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

Anno	Frazionamento	Moltiplicatore	Moltiplicatore cumulativo
2024-08-29	1:2	x0.5	x0.125
2013-09-03	1:4	x0.25	x0.25

Anno

Frazionamento

Moltiplicatore

Moltiplicatore cumulativo

2024-08-29

1:2

x0.5

x0.125

2013-09-03

1:4

x0.25

Azienda	Numero di frazionamenti azionari	Moltiplicatore cumulativo	Il paese
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Azienda

Numero di frazionamenti azionari

Moltiplicatore cumulativo

Il paese